Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma
further confirming the direct interaction of P53 and Bax
1007/s00404-013-2977-7
Molecular Weight: 396
01] to immobility time
RU-SKI 43 Hydrochloride Size:Solid 2 mg Phase II study of theRU SKI 43 is an inhibitor of Hat. It blocks palmitoylation of Shh without affecting palmitoylation of H Ras or Fyn, myristoylation of c Src, or acylation of Wnt3a. RU SKI 43 reduced pancreatic cancer cell proliferation and Gli 1 activation through Smoothened independent non canonical signaling. In addition, RU SKI 43 treatment inhibited two key proliferative pathways regulated by Akt and mTOR. Product information CAS Number: 1782573 67 4 Molecular
US$ 164.49
US$ 115.50
US$ 174.65
US$ 570.00
US$ 16.99
US$ 420.00
US$ 18.00
US$ 16.99
US$ 30.20
US$ 220.50
US$ 19.00